ReviewAnimals : an open access journal from MDPI2026
Effects of Dietary Butyrate Supplementation on Digestive Physiology, Feed Utilization, and Growth Performance in Crustaceans: A Meta-Analysis and Meta-Regression.
Review in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Butyrate, a short-chain fatty acid (SCFA), is increasingly recognized as a functional feed additive in aquaculture. However, its effects on crustacean health and performance remain unclear. This meta-analysis synthesizes findings from 23 studies (2011-2025) examining butyrate supplementation across four crustacean groups: shrimp, crabs, crayfish, and prawns. Effect sizes were calculated for growth performance (final body weight, specific growth rate, survival rate), feed efficiency (feed conversion ratio, protein efficiency ratio), and digestive enzyme activities (amylase, lipase, alkaline phosphatase, total protease) in freshwater and marine environments. Results indicate that butyrate supplementation generally enhanced the digestive enzyme activity in both freshwater and marine environments, although the magnitude of the effect varied among enzyme types and habitats, with freshwater species showing improvements in alkaline phosphatase, amylase, lipase, and total protease, and marine species showing improvements in amylase, lipase, and total protease. Feed efficiency improved in freshwater (protein efficiency ratio) and marine species (feed conversion ratio). Growth-related outcomes, including final body weight and survival rate, were generally improved across both environments. Dose-response analyses indicated that dietary inclusion levels of 1-2% were associated with the most consistent improvements in digestive enzyme activity and growth performance. These findings support the potential use of butyrate as a functional feed strategy to improve productivity and sustainability in crustacean aquaculture. These effects may be mediated by multiple mechanisms, including improved intestinal epithelial integrity, the modulation of gut microbiota, and the regulation of immune and metabolic processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.